Seeking Alpha

CombiMatrix (CBMX) soars 140% after SA author Biotech Breakthroughs says investors have...

CombiMatrix (CBMX) soars 140% after SA author Biotech Breakthroughs says investors have forgotten about management's fantastic early-year guidance and allowed the stock to drift down. With the earnings report and conference call imminent, they're about to get reminded. The stock's a double by the end of the month. Target hit.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs